In vitro experiments in cisplatin resistant hepatoma cells have shown reduced OCT3 expression in these cells, which resulted in lower cisplatin uptake, whereas induced OCT3 overexpression restored the sensitivity of these cells to cisplatin[36]. The gene discussed is SLC22A3; the disease is hepatocellular carcinoma.